1.1 Urologic symptom scores |
11 |
|
Mean Difference (IV, Random, 95% CI) |
Subtotals only |
1.1.1 PUL |
1 |
76 |
Mean Difference (IV, Random, 95% CI) |
‐0.30 [‐3.90, 3.30] |
1.1.2 TUMT |
4 |
304 |
Mean Difference (IV, Random, 95% CI) |
3.44 [‐0.16, 7.05] |
1.1.3 PAE |
6 |
369 |
Mean Difference (IV, Random, 95% CI) |
2.42 [0.37, 4.47] |
1.2 Urologic symptoms score (long term) |
5 |
|
Mean Difference (IV, Random, 95% CI) |
Subtotals only |
1.2.1 TUMT |
2 |
126 |
Mean Difference (IV, Random, 95% CI) |
1.45 [‐0.54, 3.44] |
1.2.2 PUL |
1 |
69 |
Mean Difference (IV, Random, 95% CI) |
4.80 [1.11, 8.49] |
1.2.3 PAE |
2 |
176 |
Mean Difference (IV, Random, 95% CI) |
2.58 [‐1.54, 6.71] |
1.3 Quality of life |
7 |
|
Mean Difference (IV, Random, 95% CI) |
Subtotals only |
1.3.1 PUL |
1 |
125 |
Mean Difference (IV, Random, 95% CI) |
0.40 [‐0.17, 0.97] |
1.3.2 TUMT |
1 |
125 |
Mean Difference (IV, Random, 95% CI) |
0.40 [‐0.17, 0.97] |
1.3.3 PAE |
5 |
309 |
Mean Difference (IV, Random, 95% CI) |
0.25 [‐0.75, 1.25] |
1.4 Quality of life (long term) |
4 |
|
Mean Difference (IV, Random, 95% CI) |
Subtotals only |
1.4.1 PAE |
2 |
176 |
Mean Difference (IV, Random, 95% CI) |
0.42 [‐0.11, 0.95] |
1.4.2 PUL |
1 |
69 |
Mean Difference (IV, Random, 95% CI) |
0.80 [0.07, 1.53] |
1.4.3 TUMT |
1 |
97 |
Mean Difference (IV, Random, 95% CI) |
0.00 [‐0.46, 0.46] |
1.5 Major adverse events |
11 |
|
Risk Ratio (M‐H, Random, 95% CI) |
Subtotals only |
1.5.1 PUL |
1 |
79 |
Risk Ratio (M‐H, Random, 95% CI) |
0.27 [0.03, 2.44] |
1.5.2 TUMT |
6 |
525 |
Risk Ratio (M‐H, Random, 95% CI) |
0.20 [0.09, 0.43] |
1.5.3 PAE |
4 |
301 |
Risk Ratio (M‐H, Random, 95% CI) |
0.67 [0.25, 1.76] |
1.6 Retreatment (short term) |
2 |
|
Risk Ratio (M‐H, Random, 95% CI) |
Subtotals only |
1.6.1 TUMT |
1 |
68 |
Risk Ratio (M‐H, Random, 95% CI) |
1.47 [0.06, 34.66] |
1.6.2 PAE |
1 |
60 |
Risk Ratio (M‐H, Random, 95% CI) |
9.76 [0.49, 194.21] |
1.7 Retreatment (long term) |
8 |
|
Risk Ratio (M‐H, Random, 95% CI) |
Subtotals only |
1.7.1 PUL |
1 |
79 |
Risk Ratio (M‐H, Random, 95% CI) |
2.39 [0.51, 11.10] |
1.7.2 TUMT |
4 |
395 |
Risk Ratio (M‐H, Random, 95% CI) |
9.71 [2.35, 40.15] |
1.7.3 PAE |
3 |
243 |
Risk Ratio (M‐H, Random, 95% CI) |
4.44 [1.24, 15.93] |
1.8 Erectile function (short term) |
3 |
|
Mean Difference (IV, Random, 95% CI) |
Subtotals only |
1.8.1 PUL |
1 |
59 |
Mean Difference (IV, Random, 95% CI) |
3.00 [0.02, 5.98] |
1.8.2 PAE |
2 |
129 |
Mean Difference (IV, Random, 95% CI) |
‐0.03 [‐6.35, 6.29] |
1.9 Erectile function (long term) |
1 |
|
Mean Difference (IV, Random, 95% CI) |
Subtotals only |
1.9.1 PUL |
1 |
57 |
Mean Difference (IV, Random, 95% CI) |
1.60 [‐0.80, 4.00] |
1.10 Erectile function (short term) |
6 |
|
Risk Ratio (M‐H, Random, 95% CI) |
Subtotals only |
1.10.1 TUMT |
4 |
278 |
Risk Ratio (M‐H, Random, 95% CI) |
0.79 [0.40, 1.55] |
1.10.2 PUL |
1 |
79 |
Risk Ratio (M‐H, Random, 95% CI) |
0.11 [0.01, 2.14] |
1.10.3 PAE |
1 |
61 |
Risk Ratio (M‐H, Random, 95% CI) |
0.19 [0.02, 1.56] |
1.11 Erectile function (long term) |
1 |
|
Risk Ratio (M‐H, Random, 95% CI) |
Subtotals only |
1.11.1 TUMT |
1 |
119 |
Risk Ratio (M‐H, Random, 95% CI) |
0.49 [0.17, 1.41] |
1.12 Ejaculatory function |
1 |
|
Mean Difference (IV, Random, 95% CI) |
Subtotals only |
1.12.1 PUL (short term) |
1 |
59 |
Mean Difference (IV, Random, 95% CI) |
6.30 [4.47, 8.13] |
1.12.2 PUL (long term) |
1 |
56 |
Mean Difference (IV, Random, 95% CI) |
6.00 [3.89, 8.11] |
1.13 Ejaculatory function (short term) |
8 |
|
Risk Ratio (M‐H, Random, 95% CI) |
Subtotals only |
1.13.1 TUMT |
4 |
241 |
Risk Ratio (M‐H, Random, 95% CI) |
0.36 [0.24, 0.53] |
1.13.2 PAE |
3 |
141 |
Risk Ratio (M‐H, Random, 95% CI) |
0.26 [0.06, 1.19] |
1.13.3 PUL |
1 |
79 |
Risk Ratio (M‐H, Random, 95% CI) |
0.05 [0.00, 0.90] |
1.14 Ejaculatory function (long term) |
2 |
|
Risk Ratio (M‐H, Random, 95% CI) |
Subtotals only |
1.14.1 TUMT |
1 |
69 |
Risk Ratio (M‐H, Random, 95% CI) |
0.05 [0.00, 0.85] |
1.14.2 PAE |
1 |
50 |
Risk Ratio (M‐H, Random, 95% CI) |
0.67 [0.45, 0.98] |
1.15 Minor adverse events |
8 |
|
Risk Ratio (M‐H, Random, 95% CI) |
Subtotals only |
1.15.1 TUMT |
4 |
337 |
Risk Ratio (M‐H, Random, 95% CI) |
1.27 [0.75, 2.15] |
1.15.2 PAE |
3 |
197 |
Risk Ratio (M‐H, Random, 95% CI) |
1.26 [0.40, 4.02] |
1.15.3 PUL |
1 |
79 |
Risk Ratio (M‐H, Random, 95% CI) |
0.88 [0.70, 1.09] |
1.16 Acute urinary retention |
10 |
|
Risk Ratio (M‐H, Random, 95% CI) |
Subtotals only |
1.16.1 TUMT |
4 |
343 |
Risk Ratio (M‐H, Random, 95% CI) |
2.61 [1.05, 6.47] |
1.16.2 PAE |
5 |
367 |
Risk Ratio (M‐H, Random, 95% CI) |
1.79 [0.67, 4.77] |
1.16.3 PUL |
1 |
79 |
Risk Ratio (M‐H, Random, 95% CI) |
7.20 [0.40, 129.38] |
1.17 Indwelling urinary catheter |
1 |
|
Mean Difference (IV, Random, 95% CI) |
Subtotals only |
1.17.1 PAE |
1 |
99 |
Mean Difference (IV, Random, 95% CI) |
‐2.00 [‐2.55, ‐1.45] |
1.18 Urologic symptom scores (subgroup: age) |
11 |
749 |
Mean Difference (IV, Random, 95% CI) |
2.51 [0.85, 4.18] |
1.18.1 Average age < 65 |
2 |
100 |
Mean Difference (IV, Random, 95% CI) |
2.37 [1.25, 3.49] |
1.18.2 Average age > 65 |
9 |
649 |
Mean Difference (IV, Random, 95% CI) |
2.49 [0.19, 4.80] |
1.19 Urologic symptom scores (subgroup: severity) |
11 |
749 |
Mean Difference (IV, Random, 95% CI) |
2.51 [0.85, 4.18] |
1.19.1 IPSS < 19 |
2 |
112 |
Mean Difference (IV, Random, 95% CI) |
4.96 [‐4.74, 14.66] |
1.19.2 IPSS > 19 |
9 |
637 |
Mean Difference (IV, Random, 95% CI) |
2.17 [0.70, 3.64] |